Cook Medical today announced the launch and first use of its Advance CS coronary sinus infusion catheter and Compass CT disposable pressure transducer designed for treating heart failure patients. The CS catheter is a percutaneous balloon infusion catheter designed for use in retrograde coronary sinus infusion procedures to infuse therapeutic agents into the heart via the […]
Non-invasive glucose monitor dev RSP Systems raises $8m in Series B
Denmark-based diabetes device dev RSP Systems said today it raised approximately $7.6 million (EU €6.5 million) in a Series B round to support its non-invasive glucose monitor technology. Funds raised in the round will help support clinical trials, pursuit of regulatory approval and eventual commercialization for its glucose monitoring technology. The round was joined by […]
Glooko launches next-gen diabetes web analytics platform
Glooko said today it launched a new version of its web application, including updates to its navigation and diabetes analytics, charts and graphing capabilities. The Mountain View, Calif.-based company said the update was the result of over a year of research and development exploring “the most insightful analytics features” within its platforms. The application now […]
Gates Foundation looks to develop simple, single-use injection device for global use
The Bill and Melinda Gates Foundation this week announced it is taking requests for proposals to develop a dual-chamber, prefilled, single-dose injection device for use in remote in-home settings by low skilled healthcare workers and through self-administration. The injection device will be used for the administration of the measles-rubella vaccine in house-to-house campaigns, and for […]
Dexcom hit with legal fees in AgaMatrix patent spat
Dexcom (NSDQ:DXCM) this week was ordered to pay attorney’s fees in a spat with rival AgaMatrix over patents related to continuous glucose monitoring technology. The ruling came alongside a final judgement of non-infringement in favor of AgaMatrix from Judge S. James Otero of the US District Court for the Central District of California Western Division, according […]
Medtronic touts early vessel healing in independent 1-month Resolute Onyx DES trial
Medtronic (NYSE:MDT) today released data from an independent study of its Resolute Onyx drug-eluting stent, touting strong early vessel healing at one month in a patient population with a high percentage of patients with complex coronary artery disease. Data from the study was presented at the EuroPCR Annual Meeting in Paris, the Fridley, Minn.-based company said. […]
Teleflex to acquire QT Vascular assets, takes option on Chocolate Heart DCB
QT Vascular said today it inked a deal to sell its non-drug coated coronary products to Teleflex (NYSE:TFX), including its Chocolate XD and Glider, with an option to purchase its Chocolate Heart drug-coated coronary balloon catheter which is currently under development. Singapore-based QT Vascular has not released any financial details of the agreement, but said that it will […]
Acousia Therapeutics raises $12m
Inner-ear-focused biotech firm Acousia Therapeutics said today it raised $12 million (EU €10 million) in a Series B round of financing, with funds slated to help support their preclinical drug candidates. The Series B round was led by newly invested LBBW Venture Capital and joined by new investors Creathor Ventures and Bregua Corp and existing […]
Senseonics Q1 misses on EPS
Shares in Senseonics (NYSE:SENS) have fallen slightly today after the continuous glucose monitoring-focused medtech company posted first quarter earnings that missed on earnings per share expectations but beat sales consensus on Wall Street. The Germantown, Md.-based company posted losses of $22.3 million, or 16¢ per share, on sales of $2.9 million for the three months […]
Inovio Pharma shares fall on Q1 miss
Shares in Inovio Pharmaceuticals (NSDQ:INO) have fallen today after the biotech company missed expectations on Wall Street with its first quarter earnings results. The Plymouth Meeting, Penn.-based company posted losses of $32.4 million, or 36¢ per share, on sales of $1.5 million for the three months ended March 31, seeing losses grow 40.1% while sales shrunk […]
